Advertisement
Full Length Article| Volume 4, P123-128, 2017

Download started.

Ok

Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI

Open AccessPublished:September 30, 2017DOI:https://doi.org/10.1016/j.ejro.2017.08.003

      Abstract

      Objective

      To differentiate prostate cancer lesions in transition zone by diffusion-weighted-MRI (DW-MRI).

      Methods

      Data from a total of 63 patients who underwent preoperative DWI (b of 0–1000 s/mm2) were prospectively collected and processed by a monoexponential (DWI) model and compared with a biexponential (IVIM) model for quantitation of apparent diffusion coefficients (ADCs), perfusion fraction f, diffusivity D and pseudo-diffusivity D*. Histogram analyses were performed by outlining entire-tumor regions of interest (ROIs). These parameters (separately and combined in a logistic regression model) were used to differentiate lesions depending on histopathological analysis of Magnetic Resonance/transrectal Ultrasound (MR/TRUS) fusion-guided biopsy. The diagnostic ability of differentiate the PCa from BHP in TZ was analyzed by ROC regression. Histogram analysis of quantitative parameters and Gleason score were assessed with Spearman correlation.

      Results

      Thirty (30 foci) cases of PCa in PZ and 33 (36 foci) cases of BPH were confirmed by pathology. Mean ADC, median ADC, 10th percentile ADC, 90th percentile ADC, kurtosis and skewness of ADC and mean D values, median D and 90th percentile D differed significantly between PCa and BHP in TZ. The highest classification accuracy was achieved by the mean ADC (0.841) and mean D (0.809). A logistic regression model based on mean ADC and mean D led to an AUC of 0.873, however, the difference is not significant. There were 7 Gleason 6 areas, 9 Gleason 7 areas, 8 Gleason 8 areas, 5 Gleason 9 areas and 2 Gleason 10 areas detected from the 31 prostate cancer areas, the mean Gleason value was(7.5 ± 1.2). The mean ADC and mean D had correlation with Gleason score(r = −0.522 and r = −0.407 respectively, P < 0.05).

      Conclusion

      The diagnosis efficiency of IVIM parameters was not superior to ADC in the diagnosis of PCa in TZ. Moreover, the combination of mean ADC and mean D did not perform better than the parameters alone significantly; It is feasible to stratify the pathological grade of prostate cancer by mean ADC.

      Abbreviations:

      ADC (apparent diffusion coefficient), AUC (Area under the curve), DCE (dynamic contrast-enhanced imaging), DWI (diffusion-weighted imaging), IVIM (intravoxel incoherent motion), ADC (apparent diffusion coefficient), MRS (magnetic resonance spectroscopy), MR/TRUS (magnetic resonance/transrectal ultrasound), mpMRI (multiparametric magnetic resonance imaging), PCa (prostate cancer), PZ (peripheral zone), ROI (region of interest), T1-VIBE (T1-weighted volumetric interpolated breath-hold examination), T1WI (T1-weighed imaging), T2WI (T2-weighted imaging), TZ (transition zone)

      Keywords

      1. Introduction

      Since prostate cancer (PCa) has unfortunately become a common cancer in men in more economically-developed countries, it is significant to detect these lesions, especially in the transition zone (TZ) of prostate. It was reported that between 25% and 40% of these cancers were TZ cancers [
      • Davis J.
      • Kim W.J.
      • Ward J.F.
      • et al.
      Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci.
      ,
      • Patel V.
      • Merrick G.S.
      • Allen Z.A.
      • et al.
      The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.
      ,
      • Siegel C.
      Re Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
      ]. Because the TZ is commonly the site of origin of benign prostatic hyperplasia (BPH) [
      • McNeal J.
      • Noldus J.
      Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.
      ,
      • Reissigl A.
      • Pointner J.
      • Strasser H.
      • et al.
      Frequency and clinical significance of transition zone cancer in prostate cancer screening.
      ], which has a heterogeneous appearance, it is difficult to differential diagnose these lesions. Therefore, differentiation of PCa from BPH is always a major problem frequently missed during clinical evaluation.
      T2-weighted magnetic resonance (MR) imaging has been used widely for the evaluation of prostate cancer but with limited sensitivity and specificity [
      • Doo K.W.
      • Sung D.J.
      • Park B.J.
      • et al.
      Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
      ,
      • Wu L.M.
      • Xu J.R.
      • Ye Y.Q.
      • et al.
      The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
      ,
      • Wang X.
      • Wang J.Y.
      • Li C.M.
      • et al.
      Evaluation of the prostate imaging reporting and data system for magnetic resonance imaging diagnosis of prostate cancer in patients with prostate-specific antigen <20 ng/ml.
      ]. More advanced functional MR imaging sequences in a custom multiparametric MR imaging (mpMRI) exam have been shown to significantly improve the performance of MRI in cancer diagnosis [
      • Roethke M.C.
      • Kuru T.H.
      • Schultze S.
      • et al.
      Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
      ]. In addition, DWI has become a useful tool for differentiating malignant and benign prostatic tissue due to high contrast resolution and the quantitative apparent diffusion coefficient (ADC) [
      • Doo K.W.
      • Sung D.J.
      • Park B.J.
      • et al.
      Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
      ,
      • Li L.
      • Wang L.
      • Deng M.
      • et al.
      Feasibility study of 3-T DWI of the prostate: readout-segmented versus single-shot echo-planar imaging.
      ]. DWI reflects and measures the diffusion of water molecules within biological tissues due to thermal Brownian motion. However, because the monoexponential ADC calculated from DWI potentially mixes the diffusion of molecular and the perfusion of microcirculation blood in the capillaries, the Intravoxel Incoherent Motion (IVIM) model may better account for the pseudo-diffusion based on microvascular perfusion from tissue diffusion [
      • Le Bihan D.
      • Breton E.
      • Lallemand D.
      • et al.
      Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
      ]. In recent years, several studies examined prostate IVIM in the comparison of cancerous regions and normal tissue [
      • Shinmoto H.
      • Tamura C.
      • Soga S.
      • et al.
      An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
      ,
      • Kuru T.H.
      • Roethke M.C.
      • Stieltjes B.
      • et al.
      Intravoxel incoherent motion (IVIM) diffusion imaging in prostate cancer − what does it add?.
      ,
      • Valerio M.
      • Zini C.
      • Fierro D.
      • et al.
      3 T multiparametric MRI of the prostate: does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?.
      ] without partition of the prostate, but the comparison of DWI and IVIM for tumor in TZ has not been reported at length. In addition, the traditional manually selected regions of interest (ROIs) has been pointed out as a limitation in many studies in which the overlap of a single measurement, which may lead to interobserver variability in ROI placement [
      • Rosenkrantz A.B.
      • Niver B.E.
      • Fitzgerald E.F.
      • et al.
      Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
      ,
      • Wang H.
      • Cheng L.
      • Zhang X.
      • et al.
      Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
      ,
      • Zhang Y.D.
      • Wang Q.
      • Wu C.J.
      • et al.
      The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer.
      ]. Histogram-based analysis has become to be a more objective approach the measure the diffusion-based parameters based on an entire-tumor region, and will be used here.
      Therefore, the purpose of this study was to primarily assess the diagnostic performance of DWI (using a monoexponential fit for ADC) and IVIM (using a biexponential model) for the differential diagnosis of PCa in TZ on the basis of an entire-tumor histogram analysis, by using Magnetic Resonance/transrectal Ultrasound (MR/TRUS) targeted biopsy results as the reference (gold) standard.

      2. Materials and methods

      2.1 Patients

      This prospectively designed, single institutional study was conducted in concordance with the standards of the local ethics committee. Forty-nine consecutive subjects were recruited and underwent mpMRI at 3T between January and December 2016 before biopsy. Inclusion criteria included (1) patient having undergone no prior hormonal or radiation treatment, (2) all the diffusion imaging studies having the same parameters, (3) the diameter of proven tumors being at least 0.5 cm in size, and (4) the tumor was considered as originated from a histological zone if more than 70% of its surface was located in TZ [
      • Bouye S.
      • Potiron E.
      • Puech P.
      • et al.
      Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.
      ].

      2.2 MR acquisition

      MRI studies were carried out on a 3.0 T MR scanner (MAGNETOM Skyra, Siemens Healthcare, Erlangen, Germany) and a pelvic phased-array coil. As per the standard clinical prostate MR examination at our institution, the images obtained included transverse T1-weighted turbo spin-echo (TSE) images (repetition and echo times, 700/13 ms; flip angle, 120; section thickness, 3 mm; intersection gap, 0 mm; field of view, 320mm × 250 mm; and matrix, 384 × 336). Transverse, coronal, and sagittal T2-weighted TSE images (4000/89 ms; flip angle, 120; section thickness, 3 mm; intersection gap, 0 mm; field of view, 240mm × 240 mm; and matrix, 384 × 336) were also acquired. Finally, single-shot echo-planar imaging (6800/98 ms; flip angle, 90; field of view, 160mm × 296 mm; matrix, 192 × 130; section thickness, 3 mm; intersection gap, 0 mm; a parallel imaging factor of 2; and 13 sections) was performed with a Stejskal-Tanner diffusion module and added fat suppression pulses. Diffusion in three orthogonal directions was measured from b values of 0, 50, 100, 150, 200, 500, and 1000s/mm2, for a total scan time of 5 min and 30 s.

      2.3 Imaging and histological correlation(MR/TRUS fusion-guided biopsy)

      All suspicious lesions from the MRI examination received MRI-TRUS fusion puncture within one week of the MR. All patients were anesthesized by intravenous injection and underwent transperineal prostate biopsy. In order to plan the biopsy puncture, DICOM data of mpMRI images were guided into RVS ultrasound host, selecting the obvious and scored abnormal signal on T2WI, DWI or DCE images and marking the target lesions as ROI. Prostate sagittal scans of TRUS were used to match the ROI and the same section using urethra, prostate, ejaculatory duct cyst or cysts and other anatomical landmarks, then switched to the axial cross-section using seminal vesicle, bladder and other anatomical landmarks further to correct MRI-TRUS images synchronously. After confirming MRI-TRUS images and TRUS for prostate sagittal scan, the "+" target lesions were found in real-time. After marking each partition details, each specimen was fixed in 10% formalin and sent for a pathology puncture analysis.

      2.4 Diffusion MRI post-processing

      All images were transferred in Digital Imaging and Communications in Medicine DICOM format and post-processed offline with in-house software (FireVoxel; CAI2 R, New York University, NY) and MATLAB software (MathWorks Inc. Natick, MA, USA). The biexponential IVIM and monoexponential ADC measures were respectively post-processed.
      The following biexponential (IVIM) equation was used:
      S(b)/S0 = fe−bD∗ + (1 − f)−bD


      Where S(b) is the mean signal intensity, S0 the signal reference, b is the b value and f is the perfusion fraction. D* is the diffusion of the perfusing fraction and D is the diffusion of the non-perfusing fraction.
      The apparent diffusion coefficient (ADC) was computed on the same ROIs by linear regression from the isotropic images from each b-value according to the monoexponential equation:
      S(b)/S0 = e−bADC


      In term of the histogram analyses, a voxel analysis of each independent tumor focus was performed, and the software (PASW Statistics 22.0; IBM,Corp, NY, USA) was used to calculate a histogram analysis. The following parameters were derived from the D, D*, f and ADC maps; ADC maps included the mean, median, 10th percentile, 90th percentile, and skewness. Given that the kurtosis is the degree of peakedness of a distribution, then skewness is a measure of the degree of asymmetry of a distribution. (the n th percentile is the point at which n% of the voxel values that form the histogram are found to the left).

      2.5 Statistical analysis

      All statistical analyses were performed by using SPSS 22.0 (IBM Corp, NY, USA) and Medcalc(15.0). P values of less than 0.05 determined statistical significance. Data satisfying the assumption (mean, median, the 10th and 90th percentiles) were subjected to independent sample t-test. Conversely, data not satisfying the assumption (kurtosis, skewness) were analyzed by using the Mann–Whitney U test. The parameters that yielded significance difference were selected for measuring the accuracy by using the area under the receiver operating characteristic (ROC) curve (Az). The other significance difference parameters were added to the top two Azs in logistic model by calculating Az by the method of Au Hoang Dinh[
      • Hoang Dinh A.
      • Melodelima C.
      • Souchon R.
      • et al.
      Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study.
      ]. The correlation of the parameters and Gleason score were assessed by Spearman correlation. All interval estimations provided in this article are 95% confidence intervals (CIs).

      3. Results

      Sixty-six patents were included in this study. Thirty (31 foci) cases of PCa in PZ with a mean age of 69 ± 1.54 years and a mean PSA level of 72.13 ± 26.93 ng/ml, and 30(33 foci) cases of BPH with a mean age of 63 ± 1.47 years and a mean PSA level of 12.90 ± 1.13 ng/ml were confirmed by pathology.
      The results showed that PCa regions had significantly lower ADC values than the BHP regions in terms of histogram mean, median, 10th percentile, 90th percentile skewness and kurtosis (all p < 0.005)(Fig. 1). For the IVIM-derived D, the histogram mean, median, and the 90th percentile reflected statistically significant differences between PCa and BHP groups (all p < 0.005). For D* and f, the mean, median and 10th and 90th percentiles for D* and f differences were not significant between the two groups (all p > 0.05). All more details were showed in Table 1.
      Fig. 1
      Fig. 1A representative PCa for the histogram analysis of DW imaging measures, it shows a heterogeneous low signal intensity (SI) on T2-weighted images(a) and high SI on corresponding DW images(b, c) (b = 1000 s/mm2); The D (d), D* (e) and f(f) were obtained, respectively. The tumour boundary was then outlined and the pixel-by-pixel D (g), D* (h) and f (i) were obtained, and the corresponding histogram distributions were constructed, respectively.
      Table 1Histogram parameters of ADC and IVIM according to BHP and PCa.
      Histogram analysisBPH(n = 33)PCa(n = 30)P value
      ADC(x10−3 mm2/s)
      Mean1.59 ± 0.311.16 ± 0.28<0.001
      Median1.59 ± 0.531.14 ± 0.38<0.001
      10th percentile1.12 ± 0.210.92 ± 0.26<0.001
      90th percentile1.61 ± 0.410.94 ± 0.39<0.001
      Skewness[M(P25,P75)]0.0014 (0.0012,0.0014)0.0013(0.0013,0.0095)0.029
      Kurtosis[M(P25,P75)]0.147(−0.150,0.498)−0.087 (-0.793, 0.898)0.030
      D(x10−3 mm2/s)
      Mean1.44 ± 0.450.94 ± 0.39<0.001
      Median1.57 ± 0.791.14 ± 0.260.03
      10th percentile0.48 ± 0.390.46 ± 0.410.852
      90th percentile21.23 ± 8.419.16 ± 11.620.405
      Skewness[M(P25,P75)]1.26(0.81,1.62)1.21(0.75,1.61)0.761
      Kurtosis[M(P25,P75)]0.33 (−0.56,1.77)0.46(−0.55,2.29)0.919
      D*(x10−3 mm2/s)
      Mean14.43 ± 7.7515.79 ± 6.880.453
      Median10.25 ± 9.8511.56 ± 5.690.499
      10th percentile4.66 ± 2.803.64 ± 3.280.176
      90th percentile30.63 ± 20.8529.12 ± 19.480.763
      Skewness[M(P25,P75)]3.09(2.23,4.13)3.57(2.25,4.77)0.259
      Kurtosis[M(P25,P75)]7.50(1.36,15.52)11.17(3.38,22.09)0.628
      f(%)
      Mean14.56 ± 1.0014.97 ± 1.200.133
      Median18.61 ± 12.0416.97 ± 4.560.478
      10th percentile6.22 ± 3.006.77 ± 3.100.464
      90th percentile18.57 ± 2.2418.82 ± 0.490.541
      Skewness[M(P25,P75)]0.034(−0.691,0.513)0.155(−0.234,0.603)0.443
      Kurtosis[M(P25,P75)]−1.332(−1.760,−0.796)−1.439(−1.6945,−0.841)0.931
      Data are means ± standard deviations; Data are medians with 25th percentile and 75th percentile in the parentheses. *Difference is significant; Numbers in the parentheses are the 95% Confidence Intervals (CIs).
      Table 2 displays the results of the ROC analysis of histogram parameters that had significance difference between PCa and BHP; the Az values which were close to 0.5 were excluded. The mean ADC (0.841) and mean D (0.809) had higher Az than other histogram parameters (Fig. 2a). In Table 3, histogram parameters of D values did not add significant independent information to the ADC (p > 0.05) (Fig. 2b). The correlation of the parameters and Gleason score is showed in Table 3.
      Table 2The effectiveness of histogram parameters in differentiating PCa from BHP in TZThe Az which closed to 0.5 were excluded; Numbers in the parentheses are 95% CIs.
      Histogram analysisAz (95% CI)Sensitivity at threshold (%) (95% CI)Specificity at threshold (%) (95% CI)Youden index at thresholdPPV95%CINPV95%CI
      ADC
      Mean0.841(0.731 − 0.919)87.10(70.2 − 96.4)80.56 (64.0 − 91.8)0.67781.8(64.5 − 93.0)88.2(72.5 − 96.7)
      Median0.766(0.647 − 0.861)67.74 (48.6 − 83.3)77.78(60.8 − 89.9)0.45572.4(52.8 − 87.3)73.7(56.9 − 86.6)
      10th percentile0.729(0.606 − 0.830)61.29(42.2 − 78.2)83.33 (67.2 − 93.6)0.44676.0(54.9 − 90.6)71.4(55.4 − 84.3)
      90th percentile0.747(0.626 − 0.845)61.29(42.2 − 78.2)80.56 (64.0 − 91.8)0.41973.1(52.2 − 88.4)70.7(54.5 − 83.9)
      D
      Mean0.809(0.695 − 0.895)70.97(52.0 − 85.8)77.78 (60.8 − 89.9)0.48873.3(54.1 − 87.7)75.7(58.8 − 88.2)
      Median0.715(0.592 − 0.819)100.00(88.8 − 100.0)44.44(27.9 − 61.9)0.44460.8(46.1 − 74.2)100.0(79.4 − 100.0)
      mean ADC+ mean D
      P=0.346.
      0.873(0.769 − 0.942)87.10 (70.2 − 96.4)83.33(67.2 − 93.6)0.704381.8(64.5 − 93.0)88.2(72.5 − 96.7)
      * P = 0.346.
      Fig. 2
      Fig. 2Receiver Operating Characteristic (ROC) curves which illustrate the performance of the statistically significant difference parameters when distinguishing between PCa and BHP in TZ(a); ROC curves of combination of parameters based on mean ADC and mean D(b).
      Table 3The correlation between the parameters and Gleason score.
      ADCD
      mean−0.522
      The difference is significant;/none.
      −0.407
      The difference is significant;/none.
      mean−0.218−0.093
      10th percentile−0.167/
      90th percentile−0.286/
      a The difference is significant;/none.

      4. Discussion

      This is the first published study to evaluate more detailed information noninvasively through histogram analyses of PCa from BPH using monoexponential (DWI) and biexponential (IVIM) models. The results demonstrate that PCa and BHP in TZ can be differentially diagnosed by multiparametric ADC and IVIM MR imaging with histogram analysis. We first compared the ADC and IVIM histogram parameters obtained from the PCa and BPH in TZ in order to evaluate if there are any significant differences. All of the ADC histogram parameters, mean, median and 90th percentile D were significantly lower in PCa than BPH, indicating more heterogeneity and complexity of cellularity in a tumor region than in BPH. However, the histogram D* and f had no statistic significance difference, which means pseudo-perfusion may contribute little to the diffusivity for detecting PCa in TZ. Conversely, in our results, spearman coefficient analysis revealed significant negative correlations between Gleason score and mean ADC and mean D, the statistic difference is significant, in the similar finding Yang [
      • Yang D.M.
      • Kim H.C.
      • Kim S.W.
      • et al.
      Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score.
      ] reported that Gleason score was also negative correlations with ADC and D. However, some studies [
      • Dopfert J.
      • Lemke A.
      • Weidner A.
      • et al.
      Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.
      ,
      • Shinmoto H.
      • Tamura C.
      • Soga S.
      • et al.
      An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
      ] found that decreased perfusion fraction may be involved in reducing ADC in prostate cancer. Thus, the relationship between diffusion parameters and Gleason remains controversial.
      DWI is currently considered an important component of prostate mpMRI examinations, where it has been established as an important sequence for the detection of PCa [
      • Valerio M.
      • Zini C.
      • Fierro D.
      • et al.
      3 T multiparametric MRI of the prostate: does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?.
      ]. However, as a possible improvement of DWI, it might be necessary to evaluate separately the two components of diffusion: the pure molecular diffusion and the perfusion-related diffusion (pseudo-diffusion) originating from capillary microcirculation. IVIM, by applying a biexponential model, allows the extraction of pure molecular diffusion parameters (D) and perfusion-related diffusion parameters (D* and f), as theorized.
      In recent years, several studies have considered the relationship of IVIM with the PCa and BHP. Dopfert, J. [
      • Dopfert J.
      • Lemke A.
      • Weidner A.
      • et al.
      Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.
      ] reported that the ADC, D and f were significantly lowered in cancerous tissue to benign tissue; however, in the study of Shinmoto, H [
      • Kuru T.H.
      • Roethke M.C.
      • Stieltjes B.
      • et al.
      Intravoxel incoherent motion (IVIM) diffusion imaging in prostate cancer − what does it add?.
      ], f of prostate cancer and BPH were not significantly different. The results of those studies were inconsistent. In this study, we found that both ADC and D were excellent for detecting PCa from BHP. The idea is that in prostatic carcinoma, those parameters were clearly influenced by the amount of space available for extracellular water but was also dependent on the structural nature of this space [
      • Gibbs P.
      • Liney G.P.
      • Pickles M.D.
      • et al.
      Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
      ], and the acinar structures were replaced by the more tightly packed cancer cells.
      The D* and f calculated with the biexponential model had very large associated standard deviations, possibly reflecting physiologically based variability. The growth of prostate cancer is associated with the development of a rich blood supply fed by a large network of immature, leaky blood vessels [
      • Buckley D.
      • Roberts L.C.
      • Parker G.J.
      • et al.
      Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging–initial experience.
      ], which is why the vascular perfusion made little contribution to DWI signal in the PCa. Although their clinical value may be limited, this further demonstrates the need for this highly variable perfusion component to be excluded to increase the clinical utility of the diffusion coefficient in diagnosis, prognosis or treatment response [
      • Riches S.F.
      • Hawtin K.
      • Charles-Edwards E.M.
      • et al.
      Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.
      ].
      In this study, we first tried to combine traditional ADC with IVIM parameters, and found that the histogram of D was able to distinguish PCa from BHP in TZ, which was second to the mean ADC. In addition, median, 10th percentile, 90th percentile ADC and median D did not reflect statistical significance differences between inter-groups, had higher Az values than the kurtosis and skewness of ADC, the obtained Az for histogram skewness and kurtosis did not arrive at statistical significance by a linear regression model test. Unfortunately a logistic regression model combining the histogram parameters of ADC and D did not perform significantly better in detecting cancer in TZ than ADC alone. Therefore, our study suggests that the histogram of ADC and D provide the same information when discriminating between PCa and BHP in TZ compared with simple measurements of the mean values of these parameters. However, the lack of significant differences between the histogram of ADC and IVIM suggests that the measuring the histogram of ADC and D may not provide any additional information when discriminating between PCa and BHP in TZ.Therefore, our study suggests that measuring the histogram percentiles of ADC and IVIM values may not provide any additional information when discriminating PCa from BPH compared with simple measurements of the mean values of these parameters.
      Recently, the literature has shown that the MR/TRUS fusion-biopsy system is increasingly being used to estimate the diagnostic performance of the PI-RADS scoring system in PCa. [
      • Lawrence E.M.
      • Tang S.Y.
      • Barrett T.
      • et al.
      Prostate cancer: performance characteristics of combined T(2)W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion.
      ,
      • Rastinehad A.R.
      • Waingankar N.
      • Turkbey B.et al
      Comparison of multiparametric MRI scoring systems and the impact on cancer detection in patients undergoing MR US fusion guided prostate biopsies.
      ,
      • Roethke M.C.
      • Kuru T.H.
      • Schultze S.
      • et al.
      Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
      ]. MR/TRUS fusion-biopsy is routinely used in clinical practice to integrate into biopsy planning information gained by MRI [
      • Roethke M.
      • Anastasiadis A.G.
      • Lichy M.
      • et al.
      MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.
      ]. MRI-TRUS fusion biopsy has been reported to display a high rate of detection of clinically significant PCa with traditional TRUS biopsy [
      • Xu S.
      • Kruecker J.
      • Turkbey B.
      • et al.
      Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.
      ,
      • Roethke M.
      • Anastasiadis A.G.
      • Lichy M.
      • et al.
      MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.
      ,
      • Pinto P.A.
      • Chung P.H.
      • Rastinehad A.R.
      • et al.
      Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
      ]. Currently, TRUS biopsy of the prostate represents the gold standard for diagnosis of PCa before surgery; however, the rate of false-negative results can be as high as 35%, depending on the biopsy findings. In addition, the sensitivity and specificity for the detection of malignant lesions are limited. In contrast to traditional TRUS-guided biopsy, MRI-TRUS fusion biopsy effectively avoids the shortcomings of traditional biopsy, using the flexibility of ultrasound biopsy and electronically superimposing this on TRUS images in real time. Moreover, this study used transperineal MR/TRUS fusion biopsy. The advantages of a transperineal approach compared to a transrectal one includes reduced susceptibility to compression and mobilization of the prostate [
      • Roethke M.C.
      • Kuru T.H.
      • Schultze S.
      • et al.
      Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
      ].
      The study has a few limitations. First, there was no comparison of diagnostic efficacy located for different areas of the prostate, the future research should be allowed for a more comparable differentiation between the PCa in PZ and TZ; Second, larger patient populations would be needed to find the true correlation of histogram parameters and aggressiveness and pathological grade of the tumor. Although the patients in this study were comparable to similar studies, it is still insufficient to analyze additional potential predictor variables.
      In conclusion, our study found that mean ADC values differed between PCa and BHP in TZ. In addition, diffusivity mean D derived from IVIM could be a useful tool for discriminating PCa from BPH in TZ, However, information provided by IVIM did not lead to more improved classification results of PCa and BHP than ADC.

      Conflicts of interest

      The authors have no conflicts of interest to declare.

      Funding

      The authors have no sources of funding to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

      Acknowledgements

      The authors would like to express gratitude to all those who assisted during the writing of this research report. We also thank the departments of Ultrasound, Urology and Pathology of the First Hospital for their valuable help and feedback.
      Chunhong Hu designed the study, Jie Bao and Ximing Wang contributed equally as first authors. Jie Bao performed the literature searches and data collection, analyzed the data and interpreted the results, drafted the manuscript, and provided assistance in the final submitted manuscript and provided the image data; Jianquan Hou and Fenglin Dong provided the results of the MRI-TRUS fusion-guided biopsy. Lingchuan Guo provided the results of the pathology. All the authors read and approved of the final manuscript.
      Lastly, We thank Michael E. Mosely, PhD, Professor of Radiology at Stanford University for editing and reviewing the manuscript.

      References

        • Davis J.
        • Kim W.J.
        • Ward J.F.
        • et al.
        Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci.
        BJU Int. 2010; 105: 1386-1391
        • Patel V.
        • Merrick G.S.
        • Allen Z.A.
        • et al.
        The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning.
        Urology. 2011; 77: 1148-1152
        • Siegel C.
        Re Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
        J. Urol. 2013; 190: 881
        • McNeal J.
        • Noldus J.
        Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia.
        Urology. 1996; 48: 751-756
        • Reissigl A.
        • Pointner J.
        • Strasser H.
        • et al.
        Frequency and clinical significance of transition zone cancer in prostate cancer screening.
        Prostate. 1997; 30: 130-135
        • Doo K.W.
        • Sung D.J.
        • Park B.J.
        • et al.
        Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
        Eur. Radiol. 2012; 22: 1812-1819
        • Wu L.M.
        • Xu J.R.
        • Ye Y.Q.
        • et al.
        The clinical value of diffusion-weighted imaging in combination with T2-weighted imaging in diagnosing prostate carcinoma: a systematic review and meta-analysis.
        AJR Am. J. Roentgenol. 2012; 199: 103-110
        • Wang X.
        • Wang J.Y.
        • Li C.M.
        • et al.
        Evaluation of the prostate imaging reporting and data system for magnetic resonance imaging diagnosis of prostate cancer in patients with prostate-specific antigen <20 ng/ml.
        Chin. Med. J. (Engl.). 2016; 129: 1432-1438
        • Roethke M.C.
        • Kuru T.H.
        • Schultze S.
        • et al.
        Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.
        Eur. Radiol. 2014; 24: 344-352
        • Li L.
        • Wang L.
        • Deng M.
        • et al.
        Feasibility study of 3-T DWI of the prostate: readout-segmented versus single-shot echo-planar imaging.
        AJR Am. J. Roentgenol. 2015; 205: 70-76
        • Le Bihan D.
        • Breton E.
        • Lallemand D.
        • et al.
        Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.
        Radiology. 1988; 168: 497-505
        • Shinmoto H.
        • Tamura C.
        • Soga S.
        • et al.
        An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer.
        AJR Am. J. Roentgenol. 2012; 199: W496-500
        • Kuru T.H.
        • Roethke M.C.
        • Stieltjes B.
        • et al.
        Intravoxel incoherent motion (IVIM) diffusion imaging in prostate cancer − what does it add?.
        J. Comput. Assist. Tomogr. 2014; 38: 558-564
        • Valerio M.
        • Zini C.
        • Fierro D.
        • et al.
        3 T multiparametric MRI of the prostate: does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone?.
        Eur. J. Radiol. 2016; 85: 790-794
        • Rosenkrantz A.B.
        • Niver B.E.
        • Fitzgerald E.F.
        • et al.
        Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
        AJR Am. J. Roentgenol. 2010; 195: W344-51
        • Wang H.
        • Cheng L.
        • Zhang X.
        • et al.
        Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
        Radiology. 2010; 257: 135-143
        • Zhang Y.D.
        • Wang Q.
        • Wu C.J.
        • et al.
        The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer.
        Eur. Radiol. 2015; 25: 994-1004
        • Bouye S.
        • Potiron E.
        • Puech P.
        • et al.
        Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.
        Prostate. 2009; 69: 105-113
        • Hoang Dinh A.
        • Melodelima C.
        • Souchon R.
        • et al.
        Quantitative analysis of prostate multiparametric MR images for detection of aggressive prostate cancer in the peripheral zone: a multiple imager study.
        Radiology. 2016; 280: 117-127
        • Yang D.M.
        • Kim H.C.
        • Kim S.W.
        • et al.
        Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score.
        Clin. Imaging. 2016; 40: 445-450
        • Dopfert J.
        • Lemke A.
        • Weidner A.
        • et al.
        Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging.
        Magn. Reson. Imaging. 2011; 29: 1053-1058
        • Gibbs P.
        • Liney G.P.
        • Pickles M.D.
        • et al.
        Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
        Invest. Radiol. 2009; 44: 572-576
        • Buckley D.
        • Roberts L.C.
        • Parker G.J.
        • et al.
        Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging–initial experience.
        Radiology. 2004; 233: 709-715
        • Riches S.F.
        • Hawtin K.
        • Charles-Edwards E.M.
        • et al.
        Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients.
        NMR Biomed. 2009; 22: 318-325
        • Lawrence E.M.
        • Tang S.Y.
        • Barrett T.
        • et al.
        Prostate cancer: performance characteristics of combined T(2)W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion.
        Eur. Radiol. 2014; 24: 1497-1505
        • Rastinehad A.R.
        • Waingankar N.
        • Turkbey B.et al
        Comparison of multiparametric MRI scoring systems and the impact on cancer detection in patients undergoing MR US fusion guided prostate biopsies.
        PLoS One. 2015; 10: e0143404
        • Roethke M.
        • Anastasiadis A.G.
        • Lichy M.
        • et al.
        MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.
        World J. Urol. 2012; 30: 213-218
        • Xu S.
        • Kruecker J.
        • Turkbey B.
        • et al.
        Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.
        Comput. Aided Surg. 2008; 13: 255-264
        • Pinto P.A.
        • Chung P.H.
        • Rastinehad A.R.
        • et al.
        Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
        J. Urol. 2011; 186: 1281-1285